# South Nassau Communities Hospital – FDA Inspection, May 1, 2012

Source: https://www.keypedia.com/records/fda_inspections/south-nassau-communities-hospital/b5de6ac0-03fd-4d8f-b7b3-7c14d755c8d2
Source feed: FDA_Inspections

> FDA inspection 778439 of South Nassau Communities Hospital, May 01, 2012. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR parts 606 and 640. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 778439
- Company Name: South Nassau Communities Hospital
- Inspection Date: 2012-05-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 5

## Related Documents

- FDA Inspection 984313 - 2016-08-23
- FDA Inspection 974958 - 2016-06-29
- [FDA Inspection 875482 - 2014-04-21](https://www.keypedia.com/records/fda_inspections/south-nassau-communities-hospital/dbbff998-e293-45d5-9e46-29ae54d20e46)
- [FDA Inspection 667716 - 2010-06-04](https://www.keypedia.com/records/fda_inspections/south-nassau-communities-hospital/de8c00f6-21c8-4219-9106-d08f5be53560)

Company: https://www.keypedia.com/companies/south-nassau-communities-hospital/167709ab-f0af-460d-b947-293c5a724ed3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d